LongevityNext
Not all data is a moat; standardized, repeated, outcome-linked data is. The piece keeps the focus on evidence, commercial logic, and what would make the claim testable.
The useful question is not whether a longevity platform sounds futuristic. It is whether its claims can be tested against prediction, intervention response, replication, and clinical outcomes.
Longevity companies often talk as if their advantage lies in a proprietary clock, a sharper scan, a larger omics panel, or a more elegant algorithm. Those things matter.…